Johnson & Johnson, a global leader in pharmaceuticals and medical devices, recently announced an ambitious plan to invest over $55 billion in expanding its manufacturing capacity and research infrastructure in the United States over the next four years. This strategic move represents a 25% increase in investments compared to the previous four-year period, reflecting the company's strong commitment to bolstering its production and research capabilities on American soil.

Shares of Taiwan Semiconductor Manufacturing Co (TSMC) dropped by 2.25% on Tuesday. The decline followed the company's announcement of plans to invest $100 billion to expand manufacturing capacity in the United States. This move represents TSMC's strategic initiative to strengthen its presence in the U.S. semiconductor market.